ScholarLens Back to search
1994•British Journal of CancerOpen access

CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA

Caj Haglund, Johan Lundin, Pentti Kuusela, PJ Roberts

Open full text 59 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 59 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: CA19-9, CA 15-3, Pancreatic cancer, Stage (stratigraphy), Internal medicine, Tumor marker, Monoclonal antibody, Pancreatic disease

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA — Research Paper | ScholarLens